A new Senate bill could help stop the FDA’s slow-motion elimination of homeopathy in America—but while Congress deliberates, HHS has the power to restore access to these traditional remedies immediately. Action Alert!
Listen to the audio version of this article:
THE TOPLINE
- S. 4692, the Senate version of the Homeopathic Drug Product Safety, Quality, and Transparency Act, has been introduced by Sens. Tommy Tuberville and Mike Lee.
- The bill would create a clear statutory framework for homeopathic medicines, recognizing them as a distinct category rather than forcing them into the pharmaceutical drug approval system.
- But legislation can take years—or never eventuate. The fastest immediate solution is for HHS Secretary Robert F. Kennedy Jr. to reverse FDA’s revocation of Compliance Policy Guide 400.400—the safe harbor that once gave homeopathic medicines a workable path to market.
- ANH is pursuing a new Citizen Petition to press FDA and HHS to act now.
Imagine walking into your local pharmacy for the homeopathic remedy your family has relied on for years only to find an empty space on the shelf. No vote in Congress. No dramatic announcement. Just one more trusted product gone. Well, this isn’t imagination—it’s already happening.
This is the FDA’s “boil the frog slowly” strategy for homeopathy. Under the agency’s current position, homeopathic medicines are technically illegal, but FDA isn’t enforcing against the whole category all at once. Every product exists only at the pleasure of regulators. For some homeopathic businesses, this regulatory environment is just too risky and they’re closing shop.
We’re fighting the FDA on this on multiple fronts. ANH has focused on a legal strategy to protect homeopathy. We recently updated you on that lawsuit and our plans to file a new Citizen Petition with the FDA to put the ball back in the agency’s court. But to ensure we have multiple eggs in our basket, we’re also supporting the efforts of our allies at Americans for Homeopathy Choice to pass a bill that protects access to homeopathic medicines. Earlier this year, their bill was introduced in the House; now, we’re excited to share that it has also been introduced in the Senate.
Why This Matters
For more than 200 years, Americans have used homeopathic medicines as affordable, low-risk tools for common health concerns. These products are part of a long tradition of self-care and practitioner-guided care—not patented pharmaceuticals.
Yet that is exactly how FDA is treating them.
In 2022, FDA finalized guidance asserting that homeopathic medicines marketed without FDA approval are “unapproved new drugs.” Because homeopathic medicines cannot realistically go through the same New Drug Approval process as conventional drugs, the agency effectively put the entire category in legal limbo.
FDA says it will focus enforcement on higher-risk products. But once the agency declares an entire category illegal, the damage begins even without enforcement letters. Retailers get nervous. Manufacturers stop investing. Consumers lose access one remedy at a time.
What the Senate Bill Would Do
The Senate bill would restore common sense by recognizing that homeopathic medicines are distinct and require a framework suited to their nature.
The bill would:
- Recognize homeopathic drug products as a distinct category under federal law;
- Clarify that homeopathic products are not subject to conventional premarket drug approval;
- Require safety and quality standards appropriate to homeopathy, tied to the Homeopathic Pharmacopoeia of the United States;
- Create labeling rules allowing traditional homeopathic indications with transparency for consumers; and
- Withdraw FDA’s 2022 homeopathic drug guidance.
Homeopathy should meet standards for quality, safety, labeling, and transparency—but those standards must fit homeopathy. They should not force traditional, low-risk medicines through a pharmaceutical approval system built for patentable drugs.
Congress Is Important—But HHS Can Act Faster
ANH supports the Senate bill. It is a critical long-term solution. But it is not the emergency brake that is needed to protect access right now.
Even if the bill gains momentum, legislation takes time. After passage, FDA would still need to implement rules. Homeopathy cannot wait years while access continues to erode.
That is why, in the short-term, ANH is continuing to press forward on the legal front to get HHS to reverse FDA’s revocation of CPG 400.400. This could be done by the stroke of a pen, restoring the safe harbor that allowed responsible homeopathic products to remain on the market.
In the medium-term, ANH will push the FDA and HHS to modernize CPG 400.400. The old guidance is out of date. It should be updated to reflect current manufacturing practices, labeling standards, quality controls, and adverse-event reporting—not discarded to make homeopathy effectively unlawful.
Third, the long-term fix: Congress should pass the Homeopathic Drug Product Safety, Quality, and Transparency Act so future administrations cannot wipe out access with another guidance document.
A Century-Long Pattern
This fight did not begin with FDA’s revocation of CPG400.400 in 2019 and change in guidance in 2022. The campaign to marginalize natural medicine reaches back more than a century, including the Carnegie-funded 1910 Flexner Report, which helped reshape American medical education around a single dominant model while pushing homeopathy and other traditional systems to the margins.
Today’s FDA crackdown is a modern version of the same story: centralize control, narrow what counts as acceptable medicine, and make everything outside the pharmaceutical model fight for permission to exist.
Americans deserve access to safe, affordable, traditional health options. They deserve a government that protects choice rather than quietly eliminating it.
The Bottom Line
The Senate bill is a vital step forward. It sends a clear message: homeopathy should not be erased by bureaucratic overreach.
But HHS does not need to wait for Congress. Secretary Kennedy can act now by restoring CPG 400.400, then directing FDA to modernize it. Congress should pass S. 4692 and H.R. 7050 to make those protections permanent.
Homeopathy should not exist at FDA’s discretion. It should exist because Americans have the right to choose it.
Action Alert!
